Oxygenta Pharmaceutical LimitedBSE: OXYGENTAPH

Oxygenta Pharmaceutical Limited Press Release Oct 16 2025

· Issued by Oxygenta Pharmaceutical Limited

Intimation of Receipt of No-objection from BSE Limited (BSE) for reclassification from "Promoter/ Promoter Group" Category to "Public" Category shareholder of the Company pursuant to Regulation 31A of Securities Exchange Board of India (Listing Obligations and Disclsoure Requirements), Regulations, 2015 ("SEBI LODR").

View Attachment